All Type of News
Probe on overdue drug payment should be preceded: lawmaker
A bill, aimed at punishing medical institutions that fail to make their drug payment for over three months, has caused a debate in the National Assembly.
In the Health and Welfare Committee convened on Friday, Rep....
Dongwha Pharm teams up with Cinfa Laboratories
Dongwha Pharmaceutical, Korea’s leading drug manufacturer, said Friday that it has established a marketing and distribution partnership with a Korean unit of Spain based Cinfa Laboratories.
Under the deal, Dongwha ...
Multinational drug firms’ revenues fall 3% on slump
Twenty-six multinational drug makers saw their combined sales drop 2.6 percent in 2012 from a year earlier, an online pharmaceutical information provider said Friday, pointing to their troubles stemming from the gover...
36 Korean drug makers reap over 100 billion won in 2012 sales
Korea’s 36 listed or non-listed drug firms recorded more than 100 billion won in sales last year, data showed Friday.
Combined sales by the 36 companies rose 3 percent to 9.84 trillion won in the fiscal year 2012, ...
Drugstores threaten pharmacies
Pharmacy owners are worried about Lotte Group’s planned advance into drugstores or health and beauty store chains that sell health and beauty products and snacks. They say the food giant could further threaten sales a...
Pharmaceutical lobby groups call for careful implementation of new drug reform
Korea’s four drug lobby groups, such as the Korea Pharmaceutical Manufacturers Association, the Korea Drug Research Association, the Korean Research-based Pharmaceutical Industry Association and the Korea Biomedicine ...
KFDA grants new indication for MRI contrast agent, Gadovist
The Korea Food and Drug Administration has recently agreed to expand the indication for Bayer Healthcare’s gadolinium-based contrast agent for MR imaging, Gadovist 1.0 (gadobutrol injection). Gadovist can now be used ...
GSK keeps top spot in 2012 sales
GSK kept its number 1 ranking in terms of revenue last year from the leader board of multinational drug makers, but struggles this year against Novartis Korea which continued to overtake the top position, according to...
Big five hold 66 flagship products of over 10 billion won in annual sales
The country’s five market leaders, such as Dong-A Pharmaceutical, Daewoong Pharmaceutical, Green Cross Corp., Yuhan Corp. and Hanmi Pharmaceutical, have a total of 66 products reaping over 10 billion won in annual sal...
Pharmacies struggle with drug supply
The sale of 43 drugs in pharmacies with or without a doctor’s prescription, which has been permitted from last month, got off to a rocky start.
Under the government’s re-categorization plan of drugs, a total of 43...
